Tapi Nl Bv, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ATOMOXETINE HYDROCHLORIDE, with a corresponding US DMF Number 20499.
Remarkably, this DMF maintains an Active status since its submission on April 30, 2007, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 23, 2012, and payment made on November 13, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II